UNCPM 22322 - Adaption of the Transition of Care Model for Post-Discharge HIV-NCD Care in Lilongwe, Malawi - MLATHO
- Conditions
- HIVNoncommunicable Diseases
- Registration Number
- NCT06931431
- Lead Sponsor
- University of North Carolina, Chapel Hill
- Brief Summary
This is an implementation research study that will adapt and pilot test the Transitional Of Care Model (TCM), originally conceived and developed in the USA, for targeted use as a post-discharge intervention for adults hospitalized with comorbid HIV and NCDs in Malawi using a mixed methods approach.
- Detailed Description
This study will enroll 75 consecutive adults hospitalized with comorbid HIV and at least have one common cardiometabolic condition (e.g., hypertensive urgency, heart failure, stroke, or diabetes) and provide them with the adapted TCM according to the SOP developed in the prior phase. It is expected that 15-20% will also have comorbid opportunistic infections.
The study will evaluate the acceptability and feasibility of the adapted intervention.
Using mixed methods, including surveys and interviews, the study will evaluate the acceptability and feasibility of providing the inpatient and post-discharge components of the adapted TCM. The study will also describe key 3-month post-discharge clinical outcomes (mortality, readmission) and indicators that may mediate clinical outcomes (linkages/retention in care, adherence to antiretroviral therapy/non-communicable disease (ART/ NCDs) medications, dual control of HIV and NCDs, social demographic variables). Clinical outcomes and indicators in the pilot participants will be compared with a comparable historical control group of patients who had routine care at KCH in the recent past.
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 75
- 18 years of age or older
- living with HIV
- admitted to internal medicine
- has at least a cardiometabolic NCO as the primary or secondary reason for admission based on the HIV inpatient consultation
- patients living beyond Lilongwe urban
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Post-discharge home visits Through 3-months post-discharge Proportion of discharged participants who have a home visit by a nurse within 1 week of discharge
Completion of comprehensive needs assessment Through 3-months post-discharge Proportion of participants who have an assessment of social support, food insecurity, medication adherence self-efficacy during hospitalization or within 1 week of discharge
Feasibility rating from health worker perspective. At 3 months post-discharge Feasibility of intervention measure (FIM) score among health workers involved in the implementation of the post-discharge intervention.The FIM is a 4-item/ statement measure
1. The post-discharge intervention program seems implementable in our setting
2. The post-discharge intervention seems possible in our setting
3. The post-discharge intervention seems doable in our setting
4. The post-discharge intervention seems easy to use for our setting The FIM is measured on a five-point rating scale:( 1= completely disagree, 2= disagree,3=neither agree nor disagree, 4= agree, and 5 = completely agree) The mean score ranges from 1 to 5, with 1 indicating the least feasibility and 5 indicating the most feasibility.Feasibility rating from patient and caregiver perspective At 3 months post-discharge Feasibility of implementation measure (FIM) score among patients and caregivers who were assigned to receive the post-discharge intervention.The FIM is a 4-item/ statement measure
1. The post-discharge intervention program seems implementable in our setting
2. The post-discharge intervention seems possible in our setting
3. The post-discharge intervention seems doable in our setting
4. The post-discharge intervention seems easy to use for our setting The FIM is measured on a five-point rating scale:( 1= completely disagree, 2= disagree,3=neither agree nor disagree, 4= agree, and 5 = completely agree) The mean score ranges from 1 to 5, with 1 indicating the least feasibility and 5 the most feasibility.Reach among eligible hospitalized adults with HIV/NCD comorbidity At completion of enrollment Proportion of eligible adults admitted with HIV/NCD comorbidity who participate in the study during the enrollment period
Acceptability of Intervention Measures(AIM) rating from patient and caregiver perspective At 3 months post-discharge The AIM is a 4-item/ statement measure
1. The post-discharge intervention implementation program meets my approval
2. The post-discharge intervention is appealing to me
3. I like the post-discharge intervention
4. I welcome the post-discharge intervention The AIM is measured on a five-point rating scale:( 1= completely disagree, 2= disagree,3=neither agree nor disagree, 4= agree, and 5 = completely agree) The mean score ranges from 1 to 5, with 1 indicating poorly acceptable and five highly acceptableAcceptability of Intervention Measures(AIM) rating from Healthcare Workers perspective At 3 months post-discharge The AIM is a 4-item/ statement measure
1. The post-discharge intervention implementation program meets my approval
2. The post-discharge intervention is appealing to me
3. I like the post-discharge intervention
4. I welcome the post-discharge intervention The AIM is measured on a five-point rating scale:( 1= completely disagree, 2= disagree,3=neither agree nor disagree, 4= agree, and 5 = completely agree) The mean score ranges from 1 to 5, with 1 indicating poorly acceptable and 5 highly acceptable.Intervention Appropriateness Measure(IAM) rating from Healthcare Workers perspective At 3 months post-discharge The IAM is a 4-item/ statement measure
1. The post-discharge intervention program seems fitting in our setting
2. The post-discharge intervention seems suitable for our setting
3. The post-discharge intervention seems applicable to our setting
4. The post-discharge intervention seems a good match in our setting The IAM is measured on a five-point rating scale:( 1= completely disagree, 2= disagree,3=neither agree nor disagree, 4= agree, and 5 = completely agree) The mean score ranges from 1 to 5, with 1 indicating the least appropriate and 5 the most appropriateIntervention Appropriateness Measure(IAM) rating for patient and caregiver At 3 months post-discharge The IAM is a 4-item/ statement measure
1. The post-discharge intervention program seems fitting in our setting
2. The post-discharge intervention seems suitable for our setting
3. The post-discharge intervention seems applicable to our setting
4. The post-discharge intervention seems a good match in our setting The IAM is measured on a five-point rating scale:( 1= completely disagree, 2= disagree,3=neither agree nor disagree, 4= agree, and 5 = completely agree) The mean score ranges from 1 to 5, with 1 indicating the least appropriate and 5 the most appropriate.
- Secondary Outcome Measures
Name Time Method The number of participants re-hospitalization after discharge Through 3 months post-discharge Proportion of participants who are discharged and then readmitted
Dual control of HIV and hypertension At 3 months post-discharge Among participants with hypertension and HIV, the proportion with both HIV viral load below assay detection (\<40 copies/ml) and blood pressure below 140/90
Dual control of HIV and diabetes At 3 months post-discharge Among participants with diabetes and HIV, the proportion with HIV viral load below assay detection (\<40 copies/ml) and hemoglobin A1C \<7%
Control of hypertension At 3 months post-discharge Among participants with hypertension, the proportion with blood pressure below 140/90
Control of diabetes At 3 months post-discharge Among participants with diabetes, the proportion with hemoglobin A1C \<7%
HIV viral suppression At 3 months post-discharge The proportion with HIV viral load below assay detection (\<40 copies/ml)
All-cause post-discharge mortality Through 3-months post-discharge The proportion with death after discharge from the index admission
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Kamuzu Central Hospital
🇲🇼Lilongwe, Malawi